{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:51:42Z","timestamp":1771537902280,"version":"3.50.1"},"reference-count":290,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The current COVID-19 pandemic has highlighted the need for the research community to develop a better understanding of viruses, in particular their modes of infection and replicative lifecycles, to aid in the development of novel vaccines and much needed anti-viral therapeutics. Several viruses express proteins capable of forming pores in host cellular membranes, termed \u201cViroporins\u201d. They are a family of small hydrophobic proteins, with at least one amphipathic domain, which characteristically form oligomeric structures with central hydrophilic domains. Consequently, they can facilitate the transport of ions through the hydrophilic core. Viroporins localise to host membranes such as the endoplasmic reticulum and regulate ion homeostasis creating a favourable environment for viral infection. Viroporins also contribute to viral immune evasion via several mechanisms. Given that viroporins are often essential for virion assembly and egress, and as their structural features tend to be evolutionarily conserved, they are attractive targets for anti-viral therapeutics. This review discusses the current knowledge of several viroporins, namely Influenza A virus (IAV) M2, Human Immunodeficiency Virus (HIV)-1 Viral protein U (Vpu), Hepatitis C Virus (HCV) p7, Human Papillomavirus (HPV)-16 E5, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Open Reading Frame (ORF)3a and Polyomavirus agnoprotein. We highlight the intricate but broad immunomodulatory effects of these viroporins and discuss the current antiviral therapies that target them; continually highlighting the need for future investigations to focus on novel therapeutics in the treatment of existing and future emergent viruses.<\/jats:p>","DOI":"10.3390\/v13112165","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:24:42Z","timestamp":1635377082000},"page":"2165","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Siobhan","family":"Gargan","sequence":"first","affiliation":[{"name":"Viral Immunology Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel J.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Viral Immunology Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D02 R590 Dublin, Ireland"},{"name":"Viral Immunology Group, Royal College of Surgeons in Ireland-Medical University of Bahrain, Manama 15503, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/272694a0","article-title":"Membrane leakiness after viral infection and a new approach to the development of antiviral agents","volume":"272","author":"Carrasco","year":"1978","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","article-title":"Viroporins","volume":"552","author":"Gonzalez","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-3-319-20149-8_7","article-title":"Viroporins","volume":"18","author":"Hyser","year":"2015","journal-title":"Electrophysiol. Unconv. Channels Pores"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro2820","article-title":"Viroporins: Structure and biological functions","volume":"10","author":"Nieva","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.3390\/v7072777","article-title":"NLRP3 Inflammasome Activation by Viroporins of Animal Viruses","volume":"7","author":"Guo","year":"2015","journal-title":"Viruses"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceca.2009.05.005","article-title":"Viral calciomics: Interplays between Ca2+ and virus","volume":"46","author":"Zhou","year":"2009","journal-title":"Cell Calcium"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0042-6822(03)00103-X","article-title":"The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma","volume":"310","author":"Zhang","year":"2003","journal-title":"Virology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1084\/jem.185.7.1295","article-title":"The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules","volume":"185","author":"Kerkau","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/JVI.01373-07","article-title":"Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation","volume":"82","author":"Hussain","year":"2008","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/0008-5472.CAN-19-1771","article-title":"HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer","volume":"80","author":"Miyauchi","year":"2020","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"i6258","DOI":"10.1136\/bmj.i6258","article-title":"Influenza","volume":"355","author":"Ghebrehewet","year":"2016","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"To, J., and Torres, J. (2019). Viroporins in the Influenza Virus. Cells, 8.","DOI":"10.3390\/cells8070654"},{"key":"ref_13","unstructured":"World Health Organization (2018, November 06). Influenza (Seasonal). Available online: who.int\/en\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Byrd-Leotis, L., Cummings, R.D., and Steinhauer, D.A. (2017). The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071541"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Shao, W., Li, X., Goraya, M.U., Wang, S., and Chen, J.L. (2017). Evolution of Influenza A Virus by Mutation and Re-Assortment. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081650"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1038\/s41598-019-42614-y","article-title":"Structures and functions linked to genome-wide adaptation of human influenza A viruses","volume":"9","author":"Klingen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrmicro.2016.87","article-title":"Influenza virus RNA polymerase: Insights into the mechanisms of viral RNA synthesis","volume":"14","author":"Fodor","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1201-1306","article-title":"A novel influenza A virus mitochondrial protein that induces cell death","volume":"7","author":"Chen","year":"2001","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1128\/JVI.00826-09","article-title":"A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA","volume":"83","author":"Wise","year":"2009","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1222213","article-title":"An overlapping protein-coding region in influenza A virus segment 3 modulates the host response","volume":"337","author":"Jagger","year":"2012","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.celrep.2019.03.063","article-title":"The Influenza A Virus Endoribonuclease PA-X Usurps Host mRNA Processing Machinery to Limit Host Gene Expression","volume":"27","author":"Gaucherand","year":"2019","journal-title":"Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1128\/JVI.02656-12","article-title":"Identification of novel influenza A virus proteins translated from PA mRNA","volume":"87","author":"Muramoto","year":"2013","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-422X-6-68","article-title":"The directionality of the nuclear transport of the influenza A genome is driven by selective exposure of nuclear localization sequences on nucleoprotein","volume":"6","author":"Wu","year":"2009","journal-title":"Virol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/viro.1998.9555","article-title":"Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site","volume":"254","author":"Shimizu","year":"1999","journal-title":"Virology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.1093\/emboj\/19.24.6751","article-title":"Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1","volume":"19","author":"Neumann","year":"2000","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0042-6822(91)90075-M","article-title":"Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel","volume":"180","author":"Sugrue","year":"1991","journal-title":"Virology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","article-title":"Unpacking the incoming influenza virus","volume":"69","author":"Helenius","year":"1992","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1083\/jcb.133.4.733","article-title":"The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus","volume":"133","author":"Sakaguchi","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/jvi.68.2.911-919.1994","article-title":"Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport","volume":"68","author":"Takeuchi","year":"1994","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1074\/jbc.274.14.9854","article-title":"Selective perturbation of early endosome and\/or trans-Golgi network pH but not lysosome pH by dose-dependent expression of influenza M2 protein","volume":"274","author":"Henkel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.1073\/pnas.94.21.11301","article-title":"A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity","volume":"94","author":"Pinto","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"39880","DOI":"10.1074\/jbc.M206582200","article-title":"The gate of the influenza virus M2 proton channel is formed by a single tryptophan residue","volume":"277","author":"Tang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 Proton Channels of Influenza A and B Viruses*","volume":"281","author":"Pinto","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: A cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imr.12297","article-title":"The inflammasome: Firing up innate immunity","volume":"265","author":"Kanneganti","year":"2015","journal-title":"Immunol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"Ichinohe","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e01984-18","DOI":"10.1128\/JVI.01984-18","article-title":"Autophagy Promotes Replication of Influenza A Virus In Vitro","volume":"93","author":"Wang","year":"2019","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.biocel.2016.01.012","article-title":"Autophagy is involved in regulating influenza A virus RNA and protein synthesis associated with both modulation of Hsp90 induction and mTOR\/p70S6K signaling pathway","volume":"72","author":"Liu","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ra16","DOI":"10.1126\/scisignal.2001931","article-title":"Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection","volume":"5","author":"Sun","year":"2012","journal-title":"Sci. Signal."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes","volume":"6","author":"Gannage","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","article-title":"A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability","volume":"15","author":"Beale","year":"2014","journal-title":"Cell Host Microbe"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/15548627.2019.1580089","article-title":"Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s13238-010-0115-x","article-title":"Interaction of Hsp40 with influenza virus M2 protein: Implications for PKR signaling pathway","volume":"1","author":"Guan","year":"2010","journal-title":"Protein Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1073\/pnas.94.1.97","article-title":"The molecular chaperone hsp40 regulates the activity of P58IPK, the cellular inhibitor of PKR","volume":"94","author":"Melville","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15538","DOI":"10.1016\/S0021-9258(18)47759-9","article-title":"Autophosphorylation of the protein kinase dependent on double-stranded RNA","volume":"262","author":"Galabru","year":"1987","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sharma, K., Tripathi, S., Ranjan, P., Kumar, P., Garten, R., Deyde, V., Katz, J.M., Cox, N.J., Lal, R.B., and Sambhara, S. (2011). Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020215"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2006.01.005","article-title":"Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA","volume":"349","author":"Li","year":"2006","journal-title":"Virology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1006\/viro.1995.9937","article-title":"Binding of the Influenza Virus NS1 Protein to Double-Stranded RNA Inhibits the Activation of the Protein Kinase That Phosphorylates the eIF-2 Translation Initiation Factor","volume":"214","author":"Lu","year":"1995","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/BCJ20160861","article-title":"BST-2 restricts IAV release and is countered by the viral M2 protein","volume":"474","author":"Hu","year":"2017","journal-title":"Biochem. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1074\/jbc.M117.776112","article-title":"Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection","volume":"292","author":"Fan","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1096\/fj.09-135590","article-title":"Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species","volume":"23","author":"Lazrak","year":"2009","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"L582","DOI":"10.1152\/ajplung.00314.2012","article-title":"Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity","volume":"304","author":"Londino","year":"2013","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"L845","DOI":"10.1152\/ajplung.00244.2017","article-title":"Influenza virus infection alters ion channel function of airway and alveolar cells: Mechanisms and physiological sequelae","volume":"313","author":"Londino","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.144.3620.862","article-title":"Antiviral activity of 1-adamantanamine (amantadine)","volume":"144","author":"Davies","year":"1964","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fphar.2018.01282","article-title":"Annexins in Influenza Virus Replication and Pathogenesis","volume":"9","author":"Ampomah","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/JVI.06003-11","article-title":"Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection","volume":"86","author":"Ma","year":"2012","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e01345-18","DOI":"10.1128\/mBio.01345-18","article-title":"Late Endosomal\/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus","volume":"9","author":"Musiol","year":"2018","journal-title":"mBio"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00608-13","DOI":"10.1128\/mBio.00608-13","article-title":"Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation","volume":"4","author":"Musiol","year":"2013","journal-title":"mBio"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s11427-010-4048-7","article-title":"Na+\/K+-ATPase \u03b21 subunit interacts with M2 proteins of influenza A and B viruses and affects the virus replication","volume":"53","author":"Mi","year":"2010","journal-title":"Sci. China Life Sci."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Amarelle, L., and Lecuona, E. (2018). The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082154"},{"key":"ref_63","unstructured":"World Health Organization (2019, November 15). HIV\/AIDS. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/rmv.1739","article-title":"Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis","volume":"23","author":"Nyamweya","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/COH.0000000000000534","article-title":"HIV subtype diversity worldwide","volume":"14","author":"Bbosa","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/COH.0000000000000298","article-title":"Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: Comparisons with general population","volume":"11","author":"Wandeler","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1083\/jcb.151.2.F9","article-title":"HIV-1 membrane fusion: Targets of opportunity","volume":"151","author":"Doms","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"a006890","DOI":"10.1101\/cshperspect.a006890","article-title":"HIV DNA integration","volume":"2","author":"Craigie","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/MMBR.00065-15","article-title":"HIV Genome-Wide Protein Associations: A Review of 30 Years of Research","volume":"80","author":"Li","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1128\/jvi.67.8.5056-5061.1993","article-title":"Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein","volume":"67","author":"Maldarelli","year":"1993","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Greiner, T., Bolduan, S., Hertel, B., Gross, C., Hamacher, K., Schubert, U., Moroni, A., and Thiel, G. (2016). Ion Channel Activity of Vpu Proteins Is Conserved throughout Evolution of HIV-1 and SIV. Viruses, 8.","DOI":"10.3390\/v8120325"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Sugden, S.M., Bego, M.G., Pham, T.N., and Cohen, E.A. (2016). Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses, 8.","DOI":"10.3390\/v8030067"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Khan, N., and Geiger, J.D. (2021). Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis. Viruses, 13.","DOI":"10.3390\/v13081466"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1074\/jbc.M308068200","article-title":"HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates","volume":"279","author":"Belaidouni","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Magadan, J.G., Perez-Victoria, F.J., Sougrat, R., Ye, Y., Strebel, K., and Bonifacino, J.S. (2010). Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000869"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12977-017-0345-6","article-title":"Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism","volume":"14","author":"Lukhele","year":"2017","journal-title":"Retrovirology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12958","DOI":"10.1128\/JVI.01699-10","article-title":"Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein","volume":"84","author":"Vigan","year":"2010","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/jvi.66.1.226-234.1992","article-title":"Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes","volume":"66","author":"Willey","year":"1992","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1128\/jvi.70.2.809-819.1996","article-title":"The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains","volume":"70","author":"Schubert","year":"1996","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/jvi.70.10.7108-7115.1996","article-title":"The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels","volume":"70","author":"Ewart","year":"1996","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(96)01146-5","article-title":"Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells","volume":"398","author":"Schubert","year":"1996","journal-title":"FEBS Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/viro.1998.9087","article-title":"Effects of Vpu expression on Xenopus oocyte membrane conductance","volume":"244","author":"Coady","year":"1998","journal-title":"Virology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.96.25.14336","article-title":"Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1","volume":"96","author":"Marassi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1110\/ps.37302","article-title":"Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1","volume":"11","author":"Ma","year":"2002","journal-title":"Protein Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1097-2765(04)00183-2","article-title":"Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel","volume":"14","author":"Hsu","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.bpj.2010.07.027","article-title":"Membrane potential depolarization as a triggering mechanism for Vpu-mediated HIV-1 release","volume":"99","author":"Hsu","year":"2010","journal-title":"Biophys. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/bi3011175","article-title":"HIV-1 Vpu protein mediates the transport of potassium in Saccharomyces cerevisiae","volume":"52","author":"Herrero","year":"2013","journal-title":"Biochemistry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.chom.2007.08.001","article-title":"An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein","volume":"2","author":"Neil","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Mangeat, B., Gers-Huber, G., Lehmann, M., Zufferey, M., Luban, J., and Piguet, V. (2009). HIV-1 Vpu neutralizes the antiviral factor Tetherin\/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000574"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/JVI.00242-09","article-title":"Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2\/Tetherin via a \u03b2TrCP-dependent mechanism","volume":"83","author":"Douglas","year":"2009","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mitchell, R.S., Katsura, C., Skasko, M.A., Fitzpatrick, K., Lau, D., Ruiz, A., Stephens, E.B., Margottin-Goguet, F., Benarous, R., and Guatelli, J.C. (2009). Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000450"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Janvier, K., Pelchen-Matthews, A., Renaud, J.B., Caillet, M., Marsh, M., and Berlioz-Torrent, C. (2011). The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2\/tetherin down-regulation. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1001265"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"35060","DOI":"10.1074\/jbc.M109.058305","article-title":"HIV-1 accessory protein Vpu internalizes cell-surface BST-2\/tetherin through transmembrane interactions leading to lysosomes","volume":"284","author":"Iwabu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4690-8-9","article-title":"beta-TrCP is dispensable for Vpu\u2019s ability to overcome the CD317\/Tetherin-imposed restriction to HIV-1 release","volume":"8","author":"Tervo","year":"2011","journal-title":"Retrovirology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1128\/JVI.02633-10","article-title":"Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens","volume":"85","author":"Lau","year":"2011","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Kueck, T., and Neil, S.J. (2012). A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002609"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1600-0854.2005.00380.x","article-title":"The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release","volume":"7","author":"Varthakavi","year":"2006","journal-title":"Traffic"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/JVI.01795-10","article-title":"Serine-threonine ubiquitination mediates downregulation of BST-2\/tetherin and relief of restricted virion release by HIV-1 Vpu","volume":"85","author":"Tokarev","year":"2011","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1242\/jcs.003343","article-title":"Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif","volume":"120","author":"Rollason","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1074\/jbc.RA120.013280","article-title":"The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release","volume":"295","author":"Waheed","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ali, M.S., Hammonds, J., Ding, L., and Spearman, P. (2010). CAML does not modulate tetherin-mediated restriction of HIV-1 particle release. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009005"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.1128\/JVI.01786-09","article-title":"Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin","volume":"83","author":"Bego","year":"2009","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1074\/jbc.M111.296772","article-title":"HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions","volume":"287","author":"Skasko","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"McNatt, M.W., Zang, T., Hatziioannou, T., Bartlett, M., Fofana, I.B., Johnson, W.E., Neil, S.J., and Bieniasz, P.D. (2009). Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000300"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2009.01.009","article-title":"HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor","volume":"5","author":"Goffinet","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2013.03.015","article-title":"A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2\/Tetherin and enhance viral egress","volume":"441","author":"Douglas","year":"2013","journal-title":"Virology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/JVI.01800-08","article-title":"Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network","volume":"83","author":"Dube","year":"2009","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"McNatt, M.W., Zang, T., and Bieniasz, P.D. (2013). Vpu binds directly to tetherin and displaces it from nascent virions. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003299"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1074\/jbc.M114.630095","article-title":"Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly","volume":"290","author":"Lewinski","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.virol.2008.05.022","article-title":"Requirements of the membrane proximal tyrosine and dileucine-based sorting signals for efficient transport of the subtype C Vpu protein to the plasma membrane and in virus release","volume":"378","author":"Ruiz","year":"2008","journal-title":"Virology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e02362","DOI":"10.7554\/eLife.02362","article-title":"Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1","volume":"3","author":"Jia","year":"2014","journal-title":"eLife"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Casartelli, N., Sourisseau, M., Feldmann, J., Guivel-Benhassine, F., Mallet, A., Marcelin, A.G., Guatelli, J., and Schwartz, O. (2010). Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000955"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1128\/JVI.01447-10","article-title":"Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin\/BST-2-mediated restriction in T cells","volume":"84","author":"Jolly","year":"2010","journal-title":"J. Virol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12977-018-0388-3","article-title":"The HIV-1 accessory proteins Nef and Vpu downregulate total and cell surface CD28 in CD4+ T cells","volume":"15","author":"Pawlak","year":"2018","journal-title":"Retrovirology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1440-1711.2004.01204.x","article-title":"Lack of CD28 expression on HIV-specific cytotoxic T lymphocytes is associated with disease progression","volume":"82","author":"Gamberg","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virol.2013.02.021","article-title":"HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A","volume":"440","author":"Bolduan","year":"2013","journal-title":"Virology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.chom.2010.10.008","article-title":"Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu","volume":"8","author":"Shah","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2010.11.001","article-title":"HIV-1 Vpu disarms natural killer cells","volume":"8","author":"Richard","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.celrep.2014.05.015","article-title":"Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4+ T cells","volume":"7","author":"Ramirez","year":"2014","journal-title":"Cell Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1182\/blood-2009-09-243667","article-title":"Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments","volume":"116","author":"Moll","year":"2010","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1128\/JVI.05788-11","article-title":"The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR","volume":"86","author":"Matusali","year":"2012","journal-title":"J. Virol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2014.07.034","article-title":"HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain","volume":"464\u2013465","author":"Bolduan","year":"2014","journal-title":"Virology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1128\/JVI.03719-14","article-title":"Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells","volume":"89","author":"Lambele","year":"2015","journal-title":"J. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/MCB.00302-13","article-title":"CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses","volume":"33","author":"Zamai","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1128\/JVI.00611-15","article-title":"HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes","volume":"89","author":"Vassena","year":"2015","journal-title":"J. Virol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1128\/JVI.78.9.4408-4420.2004","article-title":"Human immunodeficiency virus (HIV) type 1 Vpu induces the expression of CD40 in endothelial cells and regulates HIV-induced adhesion of B-lymphoma cells","volume":"78","author":"Henderson","year":"2004","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-11-15","article-title":"HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2","volume":"11","author":"Pham","year":"2014","journal-title":"Retrovirology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JVI.02272-12","article-title":"Stimulation of NF-kappaB activity by the HIV restriction factor BST2","volume":"87","author":"Tokarev","year":"2013","journal-title":"J. Virol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","article-title":"Differential regulation of NF-\u03baB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins","volume":"10","author":"Sauter","year":"2015","journal-title":"Cell Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"15920","DOI":"10.1074\/jbc.M010533200","article-title":"The human immunodeficiency virus type 1 Vpu protein inhibits NF-\u03baB activation by interfering with \u03b2TrCP-mediated degradation of I\u03baB","volume":"276","author":"Bour","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1084\/jem.194.9.1299","article-title":"The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor \u03baB-dependent expression of antiapoptotic factors","volume":"194","author":"Akari","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e41930","DOI":"10.7554\/eLife.41930","article-title":"HIV-1 Vpu is a potent transcriptional suppressor of NF-\u03baB-elicited antiviral immune responses","volume":"8","author":"Langer","year":"2019","journal-title":"eLife"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1128\/JVI.00424-12","article-title":"Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells","volume":"86","author":"Doehle","year":"2012","journal-title":"J. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sanchez, D.J., Miranda, D., Marsden, M.D., Dizon, T.M., Bontemps, J.R., Davila, S.J., Del Mundo, L.E., Ha, T., Senaati, A., and Zack, J.A. (2015). Disruption of Type I Interferon Induction by HIV Infection of T Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137951"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1753425918803674","article-title":"HIV blocks Type I IFN signaling through disruption of STAT1 phosphorylation","volume":"24","author":"Nguyen","year":"2018","journal-title":"Innate Immun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.2001.1166","article-title":"Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein","volume":"291","author":"Handley","year":"2001","journal-title":"Virology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1462-5822.2007.01101.x","article-title":"HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes","volume":"10","author":"Guatelli","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Neil, S.J., Eastman, S.W., Jouvenet, N., and Bieniasz, P.D. (2006). HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog., 2.","DOI":"10.1371\/journal.ppat.0020039"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1128\/JVI.80.8.3765-3772.2006","article-title":"Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag","volume":"80","author":"Harila","year":"2006","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/JVI.72.6.5189-5197.1998","article-title":"Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family","volume":"72","author":"Callahan","year":"1998","journal-title":"J. Virol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/AAC.48.6.2325-2330.2004","article-title":"Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages","volume":"48","author":"Ewart","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01308-09","article-title":"Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages","volume":"54","author":"Khoury","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12981-016-0093-z","article-title":"The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells","volume":"13","author":"Khoury","year":"2016","journal-title":"AIDS Res. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/jac\/dkv389","article-title":"A Phase 1b\/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection","volume":"71","author":"Wilkinson","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Kuhl, B.D., Cheng, V., Donahue, D.A., Sloan, R.D., Liang, C., Wilkinson, J., and Wainberg, M.A. (2011). The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027660"},{"key":"ref_147","unstructured":"World Health Organization (2021, October 14). HCV Fact Sheet. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle","volume":"22","author":"Grassi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Tsukiyama-Kohara, K., and Kohara, M. (2017). Hepatitis C Virus: Viral Quasispecies and Genotypes. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010023"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1462-5822.2007.01107.x","article-title":"Early steps of the hepatitis C virus life cycle","volume":"10","author":"Dubuisson","year":"2008","journal-title":"Cell. Microbiol."},{"key":"ref_152","first-page":"71","article-title":"Assembly of a functional HCV glycoprotein heterodimer","volume":"9","author":"Lavie","year":"2007","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Alazard-Dany, N., Denolly, S., Boson, B., and Cosset, F.L. (2019). Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets. Viruses, 11.","DOI":"10.3390\/v11010030"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life cycle: An update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11262-017-1426-2","article-title":"Ultrastructural and biochemical basis for hepatitis C virus morphogenesis","volume":"53","author":"Garateix","year":"2017","journal-title":"Virus Genes"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1099\/vir.0.054338-0","article-title":"Mutations in hepatitis C virus p7 reduce both the egress and infectivity of assembled particles via impaired proton channel function","volume":"94","author":"Bentham","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"31446","DOI":"10.1074\/jbc.M110.122895","article-title":"NMR structure and ion channel activity of the p7 protein from hepatitis C virus","volume":"285","author":"Montserret","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1128\/JVI.76.8.3720-3730.2002","article-title":"Subcellular localization and topology of the p7 polypeptide of hepatitis C virus","volume":"76","author":"Cocquerel","year":"2002","journal-title":"J. Virol."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Wozniak, A.L., Griffin, S., Rowlands, D., Harris, M., Yi, M., Lemon, S.M., and Weinman, S.A. (2010). Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001087"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Boson, B., Granio, O., Bartenschlager, R., and Cosset, F.L. (2011). A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002144"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Gentzsch, J., Brohm, C., Steinmann, E., Friesland, M., Menzel, N., Vieyres, G., Perin, P.M., Frentzen, A., Kaderali, L., and Pietschmann, T. (2013). hepatitis c Virus p7 is critical for capsid assembly and envelopment. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003355"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Denolly, S., Mialon, C., Bourlet, T., Amirache, F., Penin, F., Lindenbach, B., Boson, B., and Cosset, F.L. (2017). The amino-terminus of the hepatitis C virus (HCV) p7 viroporin and its cleavage from glycoprotein E2-p7 precursor determine specific infectivity and secretion levels of HCV particle types. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006774"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.3892\/mmr.2017.7809","article-title":"Hepatitis C virus p7 induces mitochondrial depolarization of isolated liver mitochondria","volume":"16","author":"You","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.3390\/v7082826","article-title":"Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin","volume":"7","author":"Madan","year":"2015","journal-title":"Viruses"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1099\/vir.0.19634-0","article-title":"A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria","volume":"85","author":"Griffin","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"11646","DOI":"10.1073\/pnas.1834545100","article-title":"The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences","volume":"100","author":"Sakai","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature12283","article-title":"Unusual architecture of the p7 channel from hepatitis C virus","volume":"498","author":"OuYang","year":"2013","journal-title":"Nature"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1189\/jlb.2A1211-608RRRR","article-title":"Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-alpha responses","volume":"96","author":"Collins","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e12727","DOI":"10.1111\/sji.12727","article-title":"The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases","volume":"88","author":"Gao","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/me.2005-0301","article-title":"Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6\/TAK1 complex","volume":"20","author":"Heding","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1096\/fj.201800629RR","article-title":"The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-alpha via signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3","volume":"33","author":"Convery","year":"2019","journal-title":"FASEB J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1073\/pnas.1614623114","article-title":"Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein","volume":"114","author":"Qi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jir.2010.0105","article-title":"Emerging roles of FAM14 family members (G1P3\/ISG 6-16 and ISG12\/IFI27) in innate immunity and cancer","volume":"31","author":"Cheriyath","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0014-5793(02)03851-6","article-title":"The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine","volume":"535","author":"Griffin","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/135965350601100408","article-title":"Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C","volume":"11","author":"Mihm","year":"2006","journal-title":"Antivir. Ther."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.24371","article-title":"Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel","volume":"54","author":"Foster","year":"2011","journal-title":"Hepatology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"Griffin","year":"2008","journal-title":"Hepatology"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-5793(03)01453-4","article-title":"Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride","volume":"557","author":"Premkumar","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.antiviral.2010.02.312","article-title":"A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues","volume":"86","author":"Luscombe","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_180","unstructured":"WHO (2021, October 14). Human Papillomavirus (HPV) and Cervical Cancer. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papillomavirus-(hpv)-and-cervical-cancer."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biopha.2014.12.041","article-title":"Overview of high-risk HPV\u2019s 16 and 18 infected cervical cancer: Pathogenesis to prevention","volume":"70","author":"Ramakrishnan","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV Vaccination and the Risk of Invasive Cervical Cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jadohealth.2010.01.016","article-title":"Beyond cervical cancer: Burden of other HPV-related cancers among men and women","volume":"46","author":"Chaturvedi","year":"2010","journal-title":"J. Adolesc. Health"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0065-3527(08)00404-1","article-title":"Replication and partitioning of papillomavirus genomes","volume":"72","author":"McBride","year":"2008","journal-title":"Adv. Virus Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1128\/JVI.00330-13","article-title":"The Evolving Field of Human Papillomavirus Receptor Research: A Review of Binding and Entry","volume":"87","author":"Raff","year":"2013","journal-title":"J. Virol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Woodham, A.W., Da Silva, D.M., Skeate, J.G., Raff, A.B., Ambroso, M.R., Brand, H.E., Isas, J.M., Langen, R., and Kast, W.M. (2012). The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043519"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fmicb.2012.00152","article-title":"Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation","volume":"3","author":"Kajitani","year":"2012","journal-title":"Front. Microbiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","article-title":"The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53","volume":"63","author":"Scheffner","year":"1990","journal-title":"Cell"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/j.1460-2075.1989.tb08594.x","article-title":"Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product","volume":"8","author":"Werness","year":"1989","journal-title":"EMBO J."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/JVI.06243-11","article-title":"High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitors","volume":"86","author":"Wetherill","year":"2012","journal-title":"J. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-003-0111-z","article-title":"The biochemical and biological functions of human papillomavirus type 16 E5 protein","volume":"148","author":"Tsai","year":"2003","journal-title":"Arch. Virol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/JVI.01968-09","article-title":"Membrane orientation of the human papillomavirus type 16 E5 oncoprotein","volume":"84","author":"Krawczyk","year":"2010","journal-title":"J. Virol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/excr.1998.4024","article-title":"The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT","volume":"241","author":"Crusius","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/jvi.67.8.4521-4532.1993","article-title":"The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes","volume":"67","author":"Straight","year":"1993","journal-title":"J. Virol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1128\/JVI.79.9.5839-5846.2005","article-title":"Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH","volume":"79","author":"Disbrow","year":"2005","journal-title":"J. Virol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/jvi.69.5.3185-3192.1995","article-title":"The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes","volume":"69","author":"Straight","year":"1995","journal-title":"J. Virol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1128\/JVI.00831-10","article-title":"The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification","volume":"84","author":"Suprynowicz","year":"2010","journal-title":"J. Virol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/sj.onc.1208453","article-title":"HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes","volume":"24","author":"Zhang","year":"2005","journal-title":"Oncogene"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.onc.1210725","article-title":"HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells","volume":"27","author":"Suprynowicz","year":"2008","journal-title":"Oncogene"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JVI.76.1.220-231.2002","article-title":"E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis","volume":"76","author":"Zhang","year":"2002","journal-title":"J. Virol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.onc.1201312","article-title":"Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein","volume":"15","author":"Crusius","year":"1997","journal-title":"Oncogene"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/carcin\/bgp066","article-title":"Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein","volume":"30","author":"Kim","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s00018-005-5561-x","article-title":"Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK\/ ERK1,2 and PI3K\/Akt","volume":"63","author":"Kim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/carcin\/bgn236","article-title":"Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells","volume":"30","author":"Oh","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/carcin\/bgp318","article-title":"Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells","volume":"31","author":"Oh","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000076642","article-title":"The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures","volume":"47","author":"Kabsch","year":"2004","journal-title":"Intervirology"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1874357901206010249","article-title":"The invisible enemy\u2014How human papillomaviruses avoid recognition and clearance by the host immune system","volume":"6","author":"Grabowska","year":"2012","journal-title":"Open Virol. J."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Greco, D., Kivi, N., Qian, K., Leivonen, S.K., Auvinen, P., and Auvinen, E. (2011). Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021646"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"192","DOI":"10.18632\/oncotarget.803","article-title":"HPV16 E5 and KGFR\/FGFR2b interplay in differentiating epithelial cells","volume":"4","author":"Purpura","year":"2013","journal-title":"Oncotarget"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.18632\/oncotarget.3326","article-title":"HPV16 E5 deregulates the autophagic process in human keratinocytes","volume":"6","author":"Belleudi","year":"2015","journal-title":"Oncotarget"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1038\/srep07653","article-title":"HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/sj.onc.1210916","article-title":"Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression","volume":"27","author":"Kivi","year":"2008","journal-title":"Oncogene"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/or.2012.2106","article-title":"Human papillomavirus 16\/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo","volume":"29","author":"Liao","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2018.03.021","article-title":"Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes","volume":"519","author":"Scott","year":"2018","journal-title":"Virology"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-422X-5-30","article-title":"The first hydrophobic region of the HPV16 E5 protein determines protein cellular location and facilitates anchorage-independent growth","volume":"5","author":"Lewis","year":"2008","journal-title":"Virol. J."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1099\/vir.0.016295-0","article-title":"Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: Functional characterization of each transmembrane domain","volume":"91","author":"Barbaresi","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.20558","article-title":"E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I","volume":"113","author":"Ashrafi","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.22089","article-title":"E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain","volume":"119","author":"Ashrafi","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2010.07.044","article-title":"HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells","volume":"407","author":"Campo","year":"2010","journal-title":"Virology"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1083\/jcb.148.2.305","article-title":"Golgi alkalinization by the papillomavirus E5 oncoprotein","volume":"148","author":"Schapiro","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/ijc.25004","article-title":"All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization","volume":"126","author":"Cortese","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1128\/JVI.01240-08","article-title":"Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein","volume":"82","author":"Regan","year":"2008","journal-title":"J. Virol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1743-422X-4-116","article-title":"The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells","volume":"4","author":"Gruener","year":"2007","journal-title":"Virol. J."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"11614","DOI":"10.1128\/JVI.01053-10","article-title":"CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: A possible mechanism for immune evasion by HPV","volume":"84","author":"Miura","year":"2010","journal-title":"J. Virol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-12-38","article-title":"Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway","volume":"12","author":"French","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/JVI.02114-10","article-title":"Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes","volume":"85","author":"Muto","year":"2011","journal-title":"J. Virol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/carcin\/bgl172","article-title":"Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants","volume":"27","author":"Herdman","year":"2006","journal-title":"Carcinogenesis"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"e01582-19","DOI":"10.1128\/JVI.01582-19","article-title":"Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance","volume":"94","author":"Scott","year":"2020","journal-title":"J. Virol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1128\/JVI.74.19.9083-9089.2000","article-title":"Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growth","volume":"74","author":"Liu","year":"2000","journal-title":"J. Virol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0042-6822(91)90470-V","article-title":"Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7","volume":"181","author":"Meneguzzi","year":"1991","journal-title":"Virology"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1128\/CVI.00264-10","article-title":"Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D","volume":"17","author":"Diniz","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/JVI.78.3.1333-1343.2004","article-title":"Cytotoxic-T-lymphocyte human papillomavirus type 16 E5 peptide with CpG-oligodeoxynucleotide can eliminate tumor growth in C57BL\/6 mice","volume":"78","author":"Chen","year":"2004","journal-title":"J. Virol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11596-013-1189-5","article-title":"HPV16 E5 peptide vaccine in treatment of cervical cancer in vitro and in vivo","volume":"33","author":"Liao","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10529-020-02792-6","article-title":"Development of HPV(16,18,31,45) E5 and E7 peptides-based vaccines predicted by immunoinformatics tools","volume":"42","author":"Namvar","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.34303","article-title":"Anti-tumor effects of genetic vaccines against HPV major oncogenes","volume":"11","author":"Cordeiro","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/21645515.2017.1264777","article-title":"HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy","volume":"13","author":"Paolini","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biologicals.2015.07.002","article-title":"Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach","volume":"43","author":"Kumar","year":"2015","journal-title":"Biologicals"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"593161","DOI":"10.3389\/fimmu.2021.593161","article-title":"Induction of Therapeutic Protection in an HPV16-Associated Mouse Tumor Model Through Targeting the Human Papillomavirus-16 E5 Protein to Dendritic Cells","volume":"12","author":"Bonifaz","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_240","unstructured":"World Health Organization (2021, October 14). Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available online: https:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1046\/j.1440-1843.2003.00520.x","article-title":"SARS: Clinical features and diagnosis","volume":"8","author":"Hui","year":"2003","journal-title":"Respirology"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Lam, T.T.-Y., Shum, M.H.-H., Zhu, H.-C., Tong, Y.-G., Ni, X.-B., Liao, Y.-S., Wei, W., Cheung, W.Y.-M., Li, W.-J., and Li, L.-F. (2020). Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv.","DOI":"10.1101\/2020.02.13.945485"},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Xiao, S., Li, Y., Wong, T.W., and Hui, D.S.C. (2017). Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181558"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1128\/JVI.02292-10","article-title":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","volume":"85","author":"Liu","year":"2011","journal-title":"J. Virol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3201\/eid1002.030913","article-title":"Ultrastructural characterization of SARS coronavirus","volume":"10","author":"Goldsmith","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: An overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2004.10.001","article-title":"Characterization of viral proteins encoded by the SARS-coronavirus genome","volume":"65","author":"Tan","year":"2005","journal-title":"Antivir. Res."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"van Hemert, M.J., van den Worm, S.H., Knoops, K., Mommaas, A.M., Gorbalenya, A.E., and Snijder, E.J. (2008). SARS-coronavirus replication\/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000054"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"12540","DOI":"10.1073\/pnas.0605402103","article-title":"Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release","volume":"103","author":"Lu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1128\/JVI.78.13.6723-6734.2004","article-title":"A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis","volume":"78","author":"Tan","year":"2004","journal-title":"J. Virol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.febslet.2004.03.086","article-title":"Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus","volume":"565","author":"Yu","year":"2004","journal-title":"FEBS Lett."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virusres.2005.01.001","article-title":"Subcellular localization and membrane association of SARS-CoV 3a protein","volume":"109","author":"Yuan","year":"2005","journal-title":"Virus Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/JVI.01662-09","article-title":"The Open Reading Frame 3a Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Promotes Membrane Rearrangement and Cell Death","volume":"84","author":"Freundt","year":"2010","journal-title":"J. Virol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1099\/vir.0.82856-0","article-title":"Severe acute respiratory syndrome coronavirus Orf3a protein interacts with caveolin","volume":"88","author":"Padhan","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Gupta, S., Mallick, D., Banerjee, K., Sarkar, S., Lee, S.T.M., Basuchowdhuri, P., and Jana, S.S. (2021). D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1: An In Silico Study. bioRxiv.","DOI":"10.1101\/2021.03.26.437194"},{"key":"ref_260","first-page":"19","article-title":"Functional roles of 3a protein in the pathogenesis of SARS","volume":"15","author":"Tsui","year":"2009","journal-title":"Hong Kong Med. J."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","article-title":"The ORF3a protein of SARS-CoV-2 induces apoptosis in cells","volume":"17","author":"Ren","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.biocel.2009.04.019","article-title":"The ion channel activity of the SARS-coronavirus 3a protein is linked to its pro-apoptotic function","volume":"41","author":"Chan","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41419-018-0917-y","article-title":"SARS-Coronavirus Open Reading Frame-3a drives multimodal necrotic cell death","volume":"9","author":"Yue","year":"2018","journal-title":"Cell Death Dis"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"10083","DOI":"10.1128\/JVI.79.15.10083-10087.2005","article-title":"The severe acute respiratory syndrome coronavirus 3a protein up-regulates expression of fibrinogen in lung epithelial cells","volume":"79","author":"Tan","year":"2005","journal-title":"J. Virol."},{"key":"ref_265","doi-asserted-by":"crossref","unstructured":"Batra, N., De Souza, C., Batra, J., Raetz, A.G., and Yu, A.-M. (2020). The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19). Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176412"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/JVI.80.1.210-217.2006","article-title":"Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells","volume":"80","author":"Huang","year":"2006","journal-title":"J. Virol."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Minakshi, R., Padhan, K., Rani, M., Khan, N., Ahmad, F., and Jameel, S. (2009). The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0008342"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"8865","DOI":"10.1096\/fj.201802418R","article-title":"Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC","volume":"33","author":"Siu","year":"2019","journal-title":"FASEB J."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1016\/j.febslet.2006.11.046","article-title":"Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a\/X1 and 7a\/X4 proteins through NF-kappaB activation","volume":"580","author":"Kanzawa","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.devcel.2020.12.010","article-title":"ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation","volume":"56","author":"Miao","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"ref_272","unstructured":"Yang, S., Tian, M., and Johnson, A.N. (2020). SARS-CoV-2 protein ORF3a is pathogenic in Drosophila and causes phenotypes associated with COVID-19 post-viral syndrome. bioRxiv."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/jcp.25329","article-title":"Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses","volume":"231","author":"Saribas","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1002\/jcp.27715","article-title":"Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40","volume":"234","author":"Saribas","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1002\/jcb.25977","article-title":"Nuclear Magnetic Resonance Structure of the Human Polyoma JC Virus Agnoprotein","volume":"118","author":"Coric","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1128\/JVI.00146-14","article-title":"Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an \u03b1-helix encompassing the Leu\/Ile\/Phe-rich domain","volume":"88","author":"Coric","year":"2014","journal-title":"J. Virol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.virol.2010.01.011","article-title":"The polyomavirus BK agnoprotein co-localizes with lipid droplets","volume":"399","author":"Unterstab","year":"2010","journal-title":"Virology"},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Panou, M.-M., Prescott, E.L., Hurdiss, D.L., Swinscoe, G., Hollinshead, M., Caller, L.G., Morgan, E.L., Carlisle, L., M\u00fcller, M., and Antoni, M. (2018). Agnoprotein Is an Essential Egress Factor during BK Polyomavirus Infection. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030902"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12985-014-0220-1","article-title":"Agnoprotein of polyomavirus BK interacts with proliferating cell nuclear antigen and inhibits DNA replication","volume":"12","author":"Gerits","year":"2015","journal-title":"Virol. J."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"101257","DOI":"10.1016\/j.isci.2020.101257","article-title":"BK Polyomavirus Evades Innate Immune Sensing by Disrupting the Mitochondrial Network and Promotes Mitophagy","volume":"23","author":"Manzetti","year":"2020","journal-title":"iScience"},{"key":"ref_281","doi-asserted-by":"crossref","unstructured":"Suzuki, T., Orba, Y., Okada, Y., Sunden, Y., Kimura, T., Tanaka, S., Nagashima, K., Hall, W.W., and Sawa, H. (2010). The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000801"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1348-0421.2012.00484.x","article-title":"Role of JC virus agnoprotein in virion formation","volume":"56","author":"Suzuki","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.virol.2012.06.017","article-title":"JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: Evidence for its involvement in viral DNA replication","volume":"433","author":"Saribas","year":"2012","journal-title":"Virology"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1038\/sj.onc.1205744","article-title":"Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein","volume":"21","author":"Darbinyan","year":"2002","journal-title":"Oncogene"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1128\/JVI.78.16.8593-8600.2004","article-title":"Role of JC virus agnoprotein in DNA repair","volume":"78","author":"Darbinyan","year":"2004","journal-title":"J. Virol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/JVI.01680-07","article-title":"JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis","volume":"82","author":"Merabova","year":"2008","journal-title":"J. Virol."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00401-002-0526-8","article-title":"Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain","volume":"104","author":"Okada","year":"2002","journal-title":"Acta Neuropathol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/jcp.23065","article-title":"JCV agnoprotein-induced reduction in CXCL5\/LIX secretion by oligodendrocytes is associated with activation of apoptotic signaling in neurons","volume":"227","author":"Merabova","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11481-017-9770-5","article-title":"Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein","volume":"13","author":"Craigie","year":"2018","journal-title":"J. Neuroimmune Pharm."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virol.2014.07.054","article-title":"The agnoprotein of polyomavirus JC is released by infected cells: Evidence for its cellular uptake by uninfected neighboring cells","volume":"468\u2013470","author":"Otlu","year":"2014","journal-title":"Virology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2165\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:40Z","timestamp":1760167480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":290,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["v13112165"],"URL":"https:\/\/doi.org\/10.3390\/v13112165","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}